← Leaderboards
Wang Min
University Of Rochester
$16,059,498
Attributed
$16,059,498
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$16,059,498 · 7
By mechanism
R01$14,131,042 · 6
P01$1,928,456 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsSignal TransductionEndothelial CellsMediatingBlood VesselsResponseIn VivoComplexMouse ModelInflammationInflammatoryCellsIn VitroBaseBinding (Molecular Function)Pathway InteractionsProductionVascular Endothelial CellMediator Of Activation ProteinPhosphotransferasesAtherosclerosisTransgenic MiceCell PhysiologyPrevent
Grant awards (39)
CCM3-mediated exocytosis in pathogenesis of cerebral cavernous malformation$477,311
R01 · FY2019 · HL · contact PI
Stress Signaling Pathways Linking Endothelial Injury to Graft Arteriosclerosis$418,750
R01 · FY2019 · HL · contact PI
THE ROLE OF NOVEL AIP1 ISOFORM IN PATHOLOGICAL LYMPHANGIOGENESIS$502,500
R01 · FY2018 · HL · contact PI
CCM3-mediated exocytosis in pathogenesis of cerebral cavernous malformation$490,092
R01 · FY2018 · HL · contact PI
Stress Signaling Pathways Linking Endothelial Injury to Graft Arteriosclerosis$418,750
R01 · FY2018 · HL · contact PI
CCM3-mediated exocytosis in pathogenesis of cerebral cavernous malformation$502,500
R01 · FY2017 · HL · contact PI
Stress Signaling Pathways Linking Endothelial Injury to Graft Arteriosclerosis$418,750
R01 · FY2017 · HL · contact PI
The role of signaling molecule AIP1 in pathological angiogenesis$416,925
R01 · FY2016 · HL · contact PI
The role of signaling molecule AIP1 in pathological angiogenesis$410,671
R01 · FY2015 · HL · contact PI
STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS$410,006
R01 · FY2015 · HL · contact PI
The role of signaling molecule AIP1 in pathological angiogenesis$408,587
R01 · FY2014 · HL · contact PI
STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS$407,925
R01 · FY2014 · HL · contact PI
The role of signaling molecule AIP1 in pathological angiogenesis$412,739
R01 · FY2013 · HL · contact PI
STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS$395,973
R01 · FY2013 · HL · contact PI
STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS$414,688
R01 · FY2012 · HL · contact PI
Thioredoxin and Endothelial Cell Function$409,613
R01 · FY2012 · HL · contact PI
Thioredoxin and Endothelial Cell Function$413,750
R01 · FY2011 · HL · contact PI
Inhibiting JNK A New Anti-Inflammatory Strategy$519,064
R01 · FY2010 · HL · contact PI
Thioredoxin and Endothelial Cell Function$413,750
R01 · FY2010 · HL · contact PI
TNF receptor-2 signaling in arteriogenesis/angiogenesis$413,750
R01 · FY2010 · HL · contact PI
SOCS-1 and endothelial dysfunction in graft arteriosclerosis$393,102
P01 · FY2010 · HL · contact PI
Inhibiting JNK A New Anti-Inflammatory Strategy$531,779
R01 · FY2009 · HL · contact PI
TNF receptor-2 signaling in arteriogenesis/angiogenesis$413,750
R01 · FY2009 · HL · contact PI
Thioredoxin and Endothelial Cell Function$413,750
R01 · FY2009 · HL · contact PI
SOCS-1 and endothelial dysfunction in graft arteriosclerosis$381,658
P01 · FY2009 · HL · contact PI
Thioredoxin and Endothelial Cell Function$413,750
R01 · FY2008 · HL · contact PI
TNF receptor-2 signaling in arteriogenesis/angiogenesis$413,438
R01 · FY2008 · HL · contact PI
SOCS-1 and endothelial dysfunction in graft arteriosclerosis$386,065
P01 · FY2008 · HL · contact PI
TNF receptor-2 signaling in arteriogenesis/angiogenesis$412,500
R01 · FY2007 · HL · contact PI
Inhibiting JNK A New Anti-Inflammatory Strategy$387,569
R01 · FY2007 · HL · contact PI
SOCS-1 and endothelial dysfunction in graft arteriosclerosis$386,298
P01 · FY2007 · HL · contact PI
Inhibiting JNK A New Anti-Inflammatory Strategy$399,144
R01 · FY2006 · HL · contact PI
SOCS-1 and endothelial dysfunction in graft arteriosclerosis$381,333
P01 · FY2006 · HL · contact PI
Inhibiting JNK A New Anti-Inflammatory Strategy$408,750
R01 · FY2005 · HL
Inhibiting JNK A New Anti-Inflammatory Strategy$402,400
R01 · FY2004 · HL
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY$327,000
R01 · FY2003 · HL
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY$315,430
R01 · FY2002 · HL
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY$315,430
R01 · FY2001 · HL
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY$300,258
R01 · FY2000 · HL